Advances in the Treatment of Renal Cell Carcinoma
This Special Issue of Cancers focuses on new advances in the treatment of renal cell carcinoma, both surgical and pharmacological (and combinations of these), and novel approaches to tackle treatment resistance and improve our understanding of this phenomenon.
Đã lưu trong:
| Định dạng: | Online |
|---|---|
| Ngôn ngữ: | Tiếng Anh |
| Được phát hành: |
MDPI - Multidisciplinary Digital Publishing Institute
2022
|
| Những chủ đề: | |
| Truy cập trực tuyến: | ONIX_20220321_9783036529356_21 |
| Các nhãn: |
Không có thẻ, Là người đầu tiên thẻ bản ghi này!
|
| _version_ | 1869519154178949120 |
|---|---|
| collection | Directory of Open Access Books |
| description | This Special Issue of Cancers focuses on new advances in the treatment of renal cell carcinoma, both surgical and pharmacological (and combinations of these), and novel approaches to tackle treatment resistance and improve our understanding of this phenomenon. |
| format | Online |
| id | doab-20.500.12854ir-79585 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2022 |
| publishDateRange | 2022 |
| publishDateSort | 2022 |
| publisher | MDPI - Multidisciplinary Digital Publishing Institute |
| publisherStr | MDPI - Multidisciplinary Digital Publishing Institute |
| record_format | ojs |
| spelling | doab-20.500.12854ir-795852024-03-30T23:22:27Z Advances in the Treatment of Renal Cell Carcinoma Reynolds, Paul Stewart, Grant D renal cell carcinoma autophagy hydroxychloroquine chloroquine ROC-325 cysteine cathepsins cysteine cathepsin inhibitors lysosome renal cancer metastatic renal cell carcinoma immune-based combination therapies network meta-analysis PD-L1 predictive biomarker treatment TKIs mRCC biomarkers soluble factors immunotherapy renal cell carcinoma (RCC) sunitib resistance artesunate (ART) Traditional Chinese Medicine (TCM) growth inhibition ferroptosis reactive oxygen species (ROS) clear cell renal cell carcinoma ccRCC RCC kidney cancer evolution evolutionary trajectory metastatic second line therapy renal cell cancer immune checkpoint inhibitors tyrosine kinase inhibitors individualization genomic signature transcriptomic analysis thema EDItEUR::M Medicine and Nursing This Special Issue of Cancers focuses on new advances in the treatment of renal cell carcinoma, both surgical and pharmacological (and combinations of these), and novel approaches to tackle treatment resistance and improve our understanding of this phenomenon. 2022-03-21T16:27:09Z 2022-03-21T16:27:09Z 2022 book ONIX_20220321_9783036529356_21 9783036529356 9783036529349 https://directory.doabooks.org/handle/20.500.12854/79585 eng image/jpeg Attribution 4.0 International https://mdpi.com/books/pdfview/book/4966 https://mdpi.com/books/pdfview/book/4966 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-0365-2934-9 10.3390/books978-3-0365-2934-9 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783036529356 9783036529349 221 Basel open access |
| spellingShingle | renal cell carcinoma autophagy hydroxychloroquine chloroquine ROC-325 cysteine cathepsins cysteine cathepsin inhibitors lysosome renal cancer metastatic renal cell carcinoma immune-based combination therapies network meta-analysis PD-L1 predictive biomarker treatment TKIs mRCC biomarkers soluble factors immunotherapy renal cell carcinoma (RCC) sunitib resistance artesunate (ART) Traditional Chinese Medicine (TCM) growth inhibition ferroptosis reactive oxygen species (ROS) clear cell renal cell carcinoma ccRCC RCC kidney cancer evolution evolutionary trajectory metastatic second line therapy renal cell cancer immune checkpoint inhibitors tyrosine kinase inhibitors individualization genomic signature transcriptomic analysis thema EDItEUR::M Medicine and Nursing Advances in the Treatment of Renal Cell Carcinoma |
| title | Advances in the Treatment of Renal Cell Carcinoma |
| title_full | Advances in the Treatment of Renal Cell Carcinoma |
| title_fullStr | Advances in the Treatment of Renal Cell Carcinoma |
| title_full_unstemmed | Advances in the Treatment of Renal Cell Carcinoma |
| title_short | Advances in the Treatment of Renal Cell Carcinoma |
| title_sort | advances in the treatment of renal cell carcinoma |
| topic | renal cell carcinoma autophagy hydroxychloroquine chloroquine ROC-325 cysteine cathepsins cysteine cathepsin inhibitors lysosome renal cancer metastatic renal cell carcinoma immune-based combination therapies network meta-analysis PD-L1 predictive biomarker treatment TKIs mRCC biomarkers soluble factors immunotherapy renal cell carcinoma (RCC) sunitib resistance artesunate (ART) Traditional Chinese Medicine (TCM) growth inhibition ferroptosis reactive oxygen species (ROS) clear cell renal cell carcinoma ccRCC RCC kidney cancer evolution evolutionary trajectory metastatic second line therapy renal cell cancer immune checkpoint inhibitors tyrosine kinase inhibitors individualization genomic signature transcriptomic analysis thema EDItEUR::M Medicine and Nursing |
| topic_facet | renal cell carcinoma autophagy hydroxychloroquine chloroquine ROC-325 cysteine cathepsins cysteine cathepsin inhibitors lysosome renal cancer metastatic renal cell carcinoma immune-based combination therapies network meta-analysis PD-L1 predictive biomarker treatment TKIs mRCC biomarkers soluble factors immunotherapy renal cell carcinoma (RCC) sunitib resistance artesunate (ART) Traditional Chinese Medicine (TCM) growth inhibition ferroptosis reactive oxygen species (ROS) clear cell renal cell carcinoma ccRCC RCC kidney cancer evolution evolutionary trajectory metastatic second line therapy renal cell cancer immune checkpoint inhibitors tyrosine kinase inhibitors individualization genomic signature transcriptomic analysis thema EDItEUR::M Medicine and Nursing |
| url | ONIX_20220321_9783036529356_21 |